Literature DB >> 24972694

A case of neonatal alloimmune thrombocytopenia in the presence of both anti-HPA-4b and anti-HPA-5b antibody: clinical and serological analysis of the subsequent pregnancy.

Tomoko Kiyokawa1, Yangsook Koh, Kazuya Mimura, Kotarosumitomo Nakayama, Mika Hosokawa, Mikiko Sakuragi, Tamayo Morikawa, Mayumi Nakao, Hiroshi Aochi, Yasuo Fukumori, Takeshi Kanagawa, Keisuke Nagamine, Tadashi Kimura, Yoshiaki Tomiyama.   

Abstract

Neonatal alloimmune thrombocytopenia (NAIT) is induced by maternal alloantibodies raised against fetal platelet antigens inherited from the paternal parent. In contrast to Caucasians, in Asians, predominantly in Japanese, most frequently detected antibodies in NAIT are anti-HPA-4b and anti-HPA-5b. In some NAIT cases multiple alloantibodies are detected. In such cases it is very difficult to determine which antibody is the dominant antibody in NAIT. In this case report, we describe a NAIT case (first sibling) with severe thrombocytopenia and cephalhematoma in the presence of both anti-HPA-4b and anti-HPA-5b antibodies in the maternal serum. We carefully examined titers of anti-HPA antibodies during the subsequent pregnancy with HPA-4b-positive and HPA-5b-negative fetus determined by amniocentesis at gestational week 16. We administered IVIG (1 g/kg/w) to the mother from gestational week 32 to 35. The mother subsequently delivered a second sibling with normal platelet count by cesarean section. Although we could not completely rule out the involvement of anti-HPA-4b, our findings suggested that anti-HPA-5b was implicated in the NAIT in the first sibling.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24972694     DOI: 10.1007/s12185-014-1620-0

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  13 in total

1.  Anti-HPA-5b-induced neonatal alloimmune thrombocytopenia: antibody titre as a predictor. Collaborative Study Group.

Authors:  H Ohto; T Yamaguchi; C Takeuchi; Y Tohyama; A Sato; S Morita
Journal:  Br J Haematol       Date:  2000-07       Impact factor: 6.998

2.  Fetal and neonatal alloimmune thrombocytopenia: a management algorithm based on risk stratification.

Authors:  Luis D Pacheco; Richard L Berkowitz; Kenneth J Moise; James B Bussel; Janice G McFarland; George R Saade
Journal:  Obstet Gynecol       Date:  2011-11       Impact factor: 7.661

3.  Establishment of a cell line panel as an alternative source of platelet antigens for a screening assay of anti-human platelet antibodies.

Authors:  T Hayashi; E Amakishi; N Matsuyama; K Yasui; R A Furuta; Y Hori; S Tanaka; Y Fukumori; F Hirayama; M Inoue
Journal:  Transfus Med       Date:  2011-01-06       Impact factor: 2.019

4.  Fetal alloimmune thrombocytopenia.

Authors:  J B Bussel; M R Zabusky; R L Berkowitz; J G McFarland
Journal:  N Engl J Med       Date:  1997-07-03       Impact factor: 91.245

5.  A new platelet antigen system, Yuka/Yukb.

Authors:  Y Shibata; T Miyaji; Y Ichikawa; I Matsuda
Journal:  Vox Sang       Date:  1986       Impact factor: 2.144

6.  Antenatal management of alloimmune thrombocytopenia with intravenous gamma-globulin: a randomized trial of the addition of low-dose steroid to intravenous gamma-globulin.

Authors:  J B Bussel; R L Berkowitz; L Lynch; M L Lesser; M J Paidas; C L Huang; J G McFarland
Journal:  Am J Obstet Gynecol       Date:  1996-05       Impact factor: 8.661

7.  Neonatal alloimmune thrombocytopenia: antenatal management.

Authors:  R M Silver; T F Porter; D W Branch; M S Esplin; J R Scott
Journal:  Am J Obstet Gynecol       Date:  2000-05       Impact factor: 8.661

8.  The natural history of maternal immunization against foetal platelet alloantigens.

Authors:  H Ohto; S Miura; H Ariga; T Ishii; K Fujimori; S Morita
Journal:  Transfus Med       Date:  2004-12       Impact factor: 2.019

Review 9.  Neonatal alloimmune thrombocytopenia: pathogenesis, diagnosis and management.

Authors:  Julie A Peterson; Janice G McFarland; Brian R Curtis; Richard H Aster
Journal:  Br J Haematol       Date:  2013-02-06       Impact factor: 6.998

10.  Human platelet antigen-specific alloantibodies implicated in 1162 cases of neonatal alloimmune thrombocytopenia.

Authors:  Anne Davoren; Brian R Curtis; Richard H Aster; Jarice G McFarland
Journal:  Transfusion       Date:  2004-08       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.